In order to further substantiate that TRIM25 was indeed related to paclitaxel resistance in breast cancer cells, a paclitaxel-resistant MDA-MB-231 cell line (MDA-MB-231-PR) was used for the following study. Here, TRIM25 is linked to breast cancer.